Cancer Family
Childhood Hematopoietic and Lymphatic System Neoplasm
CI-CAN-00000130Explore in graph →
PediatricNon-malignant104 active trials1 approved drugs14 evidence items
- NCIt
- C208293
Loading cancer entity…
Cancer Family
CI-CAN-00000130Explore in graph →
Clinical trials
570 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05215405 | Expanded Access Program of Venetoclax and Navitoclax for Pediatric Patients with Relapsed or Refractory ALL or LL | no longer available | — | — | Kathleen LudwigOTHER | 1 | Feb 3, 2025 | clinicaltrials |
Data updated 22 days agoSource updated Feb 3, 2025source: clinicaltrials